Lilian Leung is an associate in Goodwin’s Private Equity group. Ms. Leung represents private equity firms, investment banks and public and private companies in connection with mergers and acquisitions, takeovers and privatizations, IPOs and other general corporate matters.

Prior to joining Goodwin, Ms. Leung practiced at the Hong Kong office of a major U.S. international law firm. She speaks English, Mandarin and Cantonese.

梁詩敏律师是美国高赢国际律师事务所私募股权部的一名律师。梁律师代表私募股权公司、投资银行、上市公司和私人公司处理兼并收购、接管、私有化、首次公开募股以及其他一般公司业务。

在加入高赢之前,梁律师曾就职于一家美国大型国际性律师事务所的香港办公室。梁律师通晓英语、普通话和广东话。

Areas of Practice
TÄTIGKEITSFELDER
Domaines D’Expertise
业务范围

Experience

ERFAHRUNG

EXPÉRIENCE

工作经历

Ms. Leung’s experience includes representation of:

  • Best Food Holding Company Limited (HKSE stock code: 1488) in its acquisition of New Spicy Way Fish Hotpot, which constitutes an extreme, very substantial acquisition transaction under the Hong Kong Listing Rules.*
  • Hony Capital in the US$1.1 billion acquisition of a furniture, garment and beauty business from Hong Kong-listed company Li & Fung Limited (HKSE stock code: 494).*
  • A consortium led by Hillhouse Capital and CDH in its US$5.8 billion take-private offer for Belle International Holdings Limited (HKSE stock code: 1880) by way of a scheme of arrangement.*
  • McDonald’s Corporation in its US$2.08 billion disposal of a 80% stake in its China and Hong Kong business to CITIC and The Carlyle Group.*
  • TPG, as selling shareholder, in a secondary block trade of its 100% stake in Li Ning Company Limited (HKSE stock code: 2331), one of the leading sports brand companies in China.*
  • Rundong Auto Group Company Limited (HKSE stock code: 1365) in relation to the general offer made by Rundong Fortune Investment Limited to acquire all the ordinary shares of Rundong Auto Group Company Limited.*
  • ITOCHU Corporation in the US$10 billion investment to acquire a 20% strategic stake in CITIC Limited (HKSE stock code: 267), together with Charoen Pokphand Group*
  • Luye Pharma Group Ltd. (HKSE stock code: 2186) in its RMB$6.1 billion acquisition of the entire equity interest in Beijing Jialin Pharmaceutical Co., Ltd.*
  • Trauson Holdings Company Limited (HKSE stock code: 0325) in relation to its proposed public takeover by Stryker Corporation for a total cash consideration of approximately HK$5.9 billion (approximately US$761 million).*
  • A PRC waste-to-energy company on its proposed initial public offering on the Main Board of the Hong Kong Stock Exchange.*
  • A PRC pharmaceutical company on its proposed initial public offering on the Main Board of the Hong Kong Stock Exchange.*
  • BNP Paribas, as sole global coordinator and sole sponsor, in connection with the global offering of Golden Wheel Tiandi Holdings Co. Ltd (HKSE stock code: 1232) and its listing on the Hong Kong Stock Exchange.*

*Denotes experience prior to Goodwin.

梁律师近期的工作案例包括:

  • 代表百福控股有限公司(港交所股份代号:1488)收购新辣道鱼火锅。该交易根据上市规则构成一项极端非常重大收购事项。*
  • 代表弘毅投资以11亿美元收购香港上市公司利丰(港交所股份代号:494)的家具、服装和美容业务。*
  • 代表高瓴资本和鼎晖牵头的财团以协议安排方式对百丽国际(港交所股份代号:1880)进行私有化收购,作价58亿美元。*
  • 代表麦当劳以20.8亿美元向中信和凯雷出售其中国和香港业务的80%股权。*
  • 代表作为销售股东的TPG资本,在二级市场以大宗交易方式出售中國領先的體育品牌公司之一的李宁有限公司(港交所股份代号:2331)TPG持有的股权。*
  • 代表中国润东汽车集团(港交所股份代号:1365)处理有关Rundong Fortune Investment Limited提出的全面收购要约,以收购中国润东汽车集团的所有普通股份。*
  • 代表伊藤忠与正大集团以100亿美元收购中信股份有限公司(港交所股份代号:267)的20%股份。*
  • 代表绿叶制药集团有限公司(港交所股份代号:2186)以61亿元人民币收购北京嘉林药业有限公司的全部股权。*
  • 代表创生控股有限公司(港交所股份代号:0325)处理Stryker Corporation拟以现金代价约59亿港元(约761,000,000美元)对其进行的公开收购。*
  • 代表一家中国转废为能的公司,参与其拟议在香港联合交易所主板上市及首次公开募股项目。*
  • 代表一家中国制药公司,参与其拟议在香港联合交易所主板上市及首次公开募股项目。*
  • 代表法国巴黎银行作为唯一全球协调人及独家保荐人,参与金轮天地控股有限公司(港交所股份代号:1232)的全球发售及在香港联交所上市项目。*

*代表加入高赢之前办理的交易

Credentials

WERDEGANG

RÉFÉRENCES

专业资格

Education

J.D., 2011
Chinese University of Hong Kong
B.Sc., 2007
London School of Economics and Political Science

教育背景

法学博士, 2011
中文大学
理学学士, 2007
伦敦政治经济学院

Admissions

Bar

Hong Kong SAR

执业资格

司法區

香港

Languages

Sprachen

LANGUES

语言

English
Mandarin
Cantonese
英语
普通话
广东话
Get In Touch
Get in Touch
NOUS CONTACTER
联系我们
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.

Unsere Kunden verlassen sich auf unsere erstklassige Beratung, vor allem im Hinblick auf komplexe Transaktionen und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Branchen, verwenden wir einen kooperativen und interdisziplinären Ansatz, um Fragen unserer Kunden auch in extremen Spezialsituationen einer Lösung zuzuführen. Sie wollen mehr erfahren? Kontaktieren Sie uns gerne.

Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.

客户信赖我们世界一流的咨询服务,希望获得针对复杂事务性工作与高风险诉讼的建议。我们通过协作式、跨领域的工作方法来解决客户最棘手的问题,涵盖金融、生命科学、私募股权、不动产和技术等多个行业。如需更多信息,请与我们联系。

Search Other Lawyers
ANWALTSSUCHE
Recherche par Pratique
搜寻其他律师